Episurf Medical AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EPIS-B.ST research report →
Companyepisurf.com
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint.
- CEO
- Katarina Flodström
- IPO
- 2010
- Employees
- 27
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $108.68M
- P/E
- -4.06
- P/S
- 7.99
- P/B
- 4.97
- EV/EBITDA
- -2.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -84.56%
- Op Margin
- -444.12%
- Net Margin
- -427.94%
- ROE
- -103.05%
- ROIC
- -115.27%
Growth & Income
- Revenue
- $13.50M · 3.85%
- Net Income
- $-58,200,000 · 23.42%
- EPS
- $-0.06 · 60.67%
- Op Income
- $-60,400,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $0.29
- 52W Low
- $0.02
- 50D MA
- $0.07
- 200D MA
- $0.05
- Beta
- 0.58
- Avg Volume
- 47.91M
Get TickerSpark's AI analysis on EPIS-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EPIS-B.ST Coverage
We haven't published any research on EPIS-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EPIS-B.ST Report →